Biovie Company Top Insiders

BIVI Stock  USD 1.26  0.02  1.56%   
Under 84 percent of Biovie's insiders are selling. The analysis of the overall insider sentiment regarding Biovie Inc suggests that a large number of insiders are terrified. Biovie employs about 13 people. The company is managed by 10 executives with a total tenure of roughly 8 years, averaging almost 0.0 years of service per executive, having 1.3 employees per reported executive.

Insider Sentiment 16

 Mostly Selling

 
Selling
 
Buying

Latest Trades

2023-11-30Cuong V DoAcquired 1000 @ 17.8View
2023-09-05Steve GorlinDisposed 856 @ 30.5View
2023-08-22Richard J BermanDisposed 1080 @ 35View
2023-06-07Richard J BermanDisposed 598 @ 58.1View
2023-05-22Richard J BermanDisposed 500 @ 65View
2023-03-27Richard J BermanDisposed 337 @ 85.2View
Monitoring Biovie's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biovie Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

Biovie Management Team Effectiveness

The company has return on total asset (ROA) of (0.5001) % which means that it has lost $0.5001 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9479) %, meaning that it created substantial loss on money invested by shareholders. Biovie's management efficiency ratios could be used to measure how well Biovie manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.79. The current Return On Capital Employed is estimated to decrease to -1.13. As of now, Biovie's Non Current Assets Total are increasing as compared to previous years. The Biovie's current Other Assets is estimated to increase to 5,509, while Intangible Assets are projected to decrease to under 152.5 K.
The Biovie's current Common Stock Shares Outstanding is estimated to increase to about 1.8 M, while Net Loss is projected to decrease to (47.5 M). The market capitalization of Biovie Inc is $11.23 Million. Biovie Inc shows 3.36 percent of its outstanding shares held by insiders and 3.19 percent owned by other corporate entities. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
 
Shares in Circulation  
First Issued
2012-09-30
Previous Quarter
5.2 M
Current Value
7.9 M
Avarage Shares Outstanding
1.2 M
Quarterly Volatility
2.5 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Some institutional investors establish a significant position in stocks such as Biovie in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Biovie, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Biovie Workforce Comparison

Biovie Inc is rated third in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 88.0. Biovie retains roughly 13.0 in number of employees claiming about 15% of equities under Health Care industry.

Biovie Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biovie insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biovie's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Biovie insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Biovie Notable Stakeholders

A Biovie stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Biovie often face trade-offs trying to please all of them. Biovie's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Biovie's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Cuong MBACEO PresidentProfile
Joseph MDExecutive OfficerProfile
David MorseSenior OfficerProfile
Clarence AhlemSenior OperationsProfile
Joanne CPATreasurer CFOProfile
Denise SmithSenior DevelopmentProfile
Sarah HoitChief OfficerProfile
MBA MBACEO PresProfile
Penelope MarkhamChief Scientific OfficerProfile
Christopher ReadingSenior ProgramProfile
String symbol = request.getParameter("s");

About Biovie Management Performance

The success or failure of an entity such as Biovie Inc often depends on how effective the management is. Biovie management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Biovie management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Biovie management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.75)(0.79)
Return On Capital Employed(1.08)(1.13)
Return On Assets(0.94)(0.98)
Return On Equity(1.06)(1.11)

Biovie Workforce Analysis

Traditionally, organizations such as Biovie use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Biovie within its industry.

Biovie Manpower Efficiency

Return on Biovie Manpower

Revenue Per Employee0.0
Revenue Per Executive0.0
Net Loss Per Employee1.3M
Net Loss Per Executive1.8M
Working Capital Per Employee1.4M
Working Capital Per Executive1.8M

Complementary Tools for Biovie Stock analysis

When running Biovie's price analysis, check to measure Biovie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biovie is operating at the current time. Most of Biovie's value examination focuses on studying past and present price action to predict the probability of Biovie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biovie's price. Additionally, you may evaluate how the addition of Biovie to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
AI Portfolio Prophet
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format